CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
30 hedge funds and large institutions have $1.92M invested in CASI Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$22.4K | |
| 2 | +$19.7K | |
| 3 | +$15.3K | |
| 4 |
Renaissance Technologies
New York
|
+$5.67K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.67K |
Top Sellers
| 1 | -$217K | |
| 2 | -$141K | |
| 3 | -$45K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.4K |
| 5 |
MC
Moors & Cabot
Boston,
Massachusetts
|
-$20.3K |